When does syphilitic alopecia typically become apparent after initial infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Timing of Syphilitic Alopecia After Infection

Syphilitic alopecia typically becomes noticeable 2-8 weeks after initial infection with Treponema pallidum, coinciding with the onset of secondary syphilis manifestations. 1, 2

Timeline from Infection to Hair Loss

The progression follows a predictable sequence:

  • Primary infection occurs at the point of inoculation, with the primary chancre appearing after an incubation period of approximately 2-8 weeks 1

  • Secondary syphilis develops 2-8 weeks after primary inoculation, which is when hair loss becomes clinically apparent 1, 2

  • This means hair loss typically manifests approximately 4-16 weeks (1-4 months) after the initial exposure, though it most commonly appears during the secondary stage window 1, 2

Clinical Presentation of Syphilitic Alopecia

When hair loss does occur, it presents with characteristic patterns:

  • The "moth-eaten" pattern is pathognomonic, appearing as irregular, patchy areas of hair loss scattered across the scalp 3, 4, 5

  • Diffuse alopecia can also occur, though less commonly 4, 5

  • Prevalence ranges from 3-7% in most studies, though one recent study found it in 41.6% of secondary syphilis patients when specifically examined 4, 5

Important Clinical Context

Several factors affect recognition and timing:

  • Hair loss may be the sole presenting symptom of secondary syphilis, occurring without other classic manifestations like rash or condyloma lata 3

  • Other secondary syphilis manifestations typically accompany or precede the alopecia, including the characteristic maculopapular rash involving palms and soles, generalized lymphadenopathy, fever, and malaise 2, 6

  • HIV co-infection may accelerate disease progression, potentially shortening the typical timeline and making clinical lesions more apparent 1, 2

Diagnostic Considerations

The British Association of Dermatologists guidelines specifically list secondary syphilis as a differential diagnosis for alopecia areata, emphasizing the need for serologic testing when the diagnosis is uncertain 7. This is critical because:

  • Syphilitic alopecia mimics other forms of hair loss including alopecia areata, telogen effluvium, and tinea capitis, leading to potential misdiagnosis 7, 4, 8

  • Serologic testing confirms the diagnosis, with both nontreponemal and treponemal tests required 2

  • Dermoscopy shows reduction in terminal hair number in moth-eaten areas, which can aid diagnosis 5

Treatment Response Timeline

Following appropriate treatment:

  • Hair regrowth occurs within approximately 3 months after benzathine penicillin G administration 3, 8

  • First-line treatment is benzathine penicillin G 2.4 million units IM as a single dose 1, 8

Key Clinical Pitfall

Maintain high clinical suspicion for syphilis in any patient presenting with unexplained alopecia, particularly those with risk factors for sexually transmitted infections, as hair loss may be the only initial presenting symptom and can easily be misdiagnosed as other more common causes of alopecia 3, 4, 8.

References

Guideline

Incubation Period and Disease Progression for Syphilis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Secondary Syphilis Rash

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Alopecia syphilitica, from diagnosis to treatment.

Proceedings (Baylor University. Medical Center), 2022

Guideline

Sifilis: Gejala, Penampakan, dan Pertimbangan Klinis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.